Home
Search
BIO Digital

Speakers & Presenters

Meet the experts speaking on our world-class education program.

June 8-12, 2020
Register
Search
Event Menu
Event Menu
Search General Info
Search Education
Search Partnering Companies

2020 BIO Digital Education Program

New speakers and presenters confirmed regularly, so check back frequently for updates.

Featured Speakers
Dr. Fauci
Anthony Fauci, MD
DIRECTOR, NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES, NATIONAL INSTITUTES OF HEALTH
ANTHONY S. FAUCI, MD is director of the National Institute of Allergy and Infectious Diseases (NIAID) at the U.S. National Institutes of Health,…
Paul Stoffels
Paul Stoffels, MD
VICE CHAIRMAN OF THE EXECUTIVE COMMITTEE AND CHIEF SCIENTIFIC OFFICER, JOHNSON & JOHNSON
Paul Stoffels is a visionary leader who inspires and drives transformational innovation to bring years of life and quality of life to millions of…
Sharon Chan
Sharon Chan, MBA, MPH, D. Phil
HEAD JLABS @ SHANGHAI, JOHNSON & JOHNSON INNOVATION
Sharon Chan is the Head of JLABS @ Shanghai. In this role, Sharon is responsible for setting the strategic direction and overseeing all operational…
Dr. Fauci
Paul Stoffels
Sharon Chan
All Speakers
By Count | Alphabetical
  • Show All
By Count | Alphabetical
  • Show All
By Count | Alphabetical
  • Show All
Company Type
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Speakers
All Speakers
Filter by letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
photo
Sanjay Padhi, PhD
DR, AMAZON WEB SERVICES, RESEARCH
The Immersive Medicine of the Future: At the convergence of smart sensors, virtual reality and artificial intelligence
California, United States
photo
Jisoo Pae
CEO, GENOME AND COMPANY
Genome and Company
Seongnam, Korea - South Korea
photo
Chorom Pak
PRESIDENT AND CEO, LYNX BIOSCIENCES
How Can the Liquid Biopsy Market Realize Its $30B Potential?
San Diego, California, United States
photo
Joe Palca
CORRESPONDENT, SCIENCE DESK, NPR
Science on the Front Lines & on the Front Page
United States
photo
Deborah Palestrant
PARTNER, HEAD OF 4:59, 5AM VENTURES
The Business of Innovation: Evolving Models for Life Science Startups to Drive Efficiency and Maximize Value
Boston, Massachusetts, United States
photo
Lauren Palestrini, PhD
DIRECTOR OF RESEARCH, MEDICAL TECHNOLOGY ENTERPRISE CONSORTIUM
How to Leverage Military Non-Dilutive Funding for Your Product Development Plan
Summerville, South Carolina, United States
photo
Pan Pan
ASSOCIATE DIRECTOR, BUSINESS DEVELOPMENT, KLUS PHARMA INC.
KLUS Pharma Inc
Cranbury, New Jersey, United States
photo
Agnès Pannier-Runacher
DEPUTY MINISTER TO THE MINISTER OF ECONOMY AND FINANCE, FRANCE
International Plenary Session: How are Global Leaders Collaborating to Combat the Pandemic?
France
photo
Corrado Panno
VP, BUSINESS DEVELOPMENT, MAGELLAN METHOD, A DIVISION OF MAGELLAN RX MANAGEMENT
Reinventing Partnerships to Deliver Value for Patients & Society
photo
Kate Papp, PhD
CLINICAL NEUROPSYCHOLOGIST; ASSISTANT PROFESSOR, BRIGHAM AND WOMEN'S HOSPITAL; MASSACHUSETTS GENERAL HOSPITAL; HARVARD MEDICAL SCHOOL
The Emerging Role of Digital Biomarkers in Cognitive Impairment
Boston, Massachusetts, United States
photo
Valerie Paradiz, PhD
VICE PRESIDENT OF SERVICES AND SUPPORTS, AUTISM SPEAKS
Patient-Centric 2.0: Are We Ready for Decentralized Trials?
photo
John (Won-jun) Park
CMO (CHIEF MARKETING OFFICER), AIDOT INC.
AIDOT Inc.
Seoul, Korea - South Korea
photo
Kyungmin Park
TEAM LEADER, SEOUL METROPOLITAN GOVERNMENT
Seoul Metropolitan Government_Invest Seoul Center, Seoul Business Agency
Seoul, Korea - South Korea
photo
Yoon Jeong Park, PhD
CTO , NIBEC
NIBEC
SEOUL, Korea - South Korea
photo
Hyunwoo Park
CEO, HEALTH PARK CO., LTD.
Health Park co.,ltd.
Seoul, Korea - South Korea
photo
Jerry Parrott
PRESIDENT AND CEO, BIOMARKER STRATEGIES, LLC
BioMarker Strategies, LLC
Rockville, Maryland, United States
photo
Richard Pascoe
CHAIRMAN AND CEO, HISTOGEN INC.
Histogen, Inc.
San Diego, California, United States
photo
Danielle Pasqualone, JD, PhD
VICE PRESIDENT, INTELLECTUAL PROPERTY, ALECTOR LLC
WHY PATENTS STILL MATTER: Building Your Patent Portfolio for Global Collaborations
South San Francisco, California, United States
photo
Andy Pasternak
CHIEF STRATEGY OFFICER, HORIZON THERAPEUTICS
Is It Time to Reconsider M&A’s Role in Portfolio Building?
Horizon Therapeutics
Lake Forest, Illinois, United States
photo
Bakul Patel
DIRECTOR, DIVISION OF DIGITAL HEALTH, CENTER FOR DEVICES AND RADIOLOGICAL HEALTH, FDA
Digital Health: Innovation Meets Regulation
United States
photo
Snehal Patel
CEO, GREENWICH LIFESCIENCES
Greenwich LifeSciences
Sugar Land, Texas, United States
photo
Bray Patrick-Lake
DIRECTOR, STAKEHOLDER ENGAGEMENT, DUKE CLINICAL RESEARCH INSTITUTE
Addressing the Unmet Need in Cardiovascular Disease Development
photo
Scott Paul
PRESIDENT, ALLIANCE FOR AMERICAN MANUFACTURING
International Trade in the Times of COVID-19
photo
Ryan Pawell
CHIEF EXECUTIVE OFFICER, INDEE LABS
Indee Labs
Berkeley, California, United States
photo
Cindy Perettie, MBA, BSc
CHIEF EXECUTIVE OFFICER , FOUNDATION MEDICINE
How Can the Liquid Biopsy Market Realize Its $30B Potential?
Cambridge, Massachusetts, United States
photo
Ward Peterson, PhD
PRESIDENT AND CEO, SYMBERIX, INC.
Symberix, Inc.
Durham, North Carolina, United States
photo
Chad Pettit
EXECUTIVE DIRECTOR, GLOBAL VALUE, ACCESS AND POLICY, BIOSIMILARS, AMGEN
How can the U.S. cultivate a strong and competitive biosimilars market?
Thousand Oaks, California, United States
photo
Ed Pezalla, MD, MPH
FOUNDER AND CEO, ENLIGHTENMENT BIOCONSULT, LLC
Payers and Digital Therapeutics: How to Get Coverage When Doctors Prescribe Software
Daytona Beach, Florida, United States
photo
Olivier Philippe
DIRECTOR OF BUSINESS DEVELOPMENT & CORPORATE RELATIONS, BIOPôLE SA
Biopôle SA
Epalinges, Switzerland
photo
Maria Pineda
CO-FOUNDER & CEO, ENVISAGENICS
Envisagenics
New York, New York, United States
photo
Agnieszka Piotrowska
ALLIANCE MANAGER, ARDIGEN
Ardigen
Krakow, Poland
photo
Dominic Piscitelli
CHIEF FINANCIAL OFFICER, ORIC PHARMA
Capital Markets Crystal Ball: Strategies for Equity Financing
photo
Radu Pislariu
PRESIDENT & CEO, LAURENT PHARMACEUTICALS
Drug repurposing for new treatments of rare diseases: the academic, biotech, and investor perspective
Montreal, Quebec, Canada
photo
Peter Pitts
PRESIDENT AND CO-FOUNDER, CENTER FOR MEDICINE IN THE PUBLIC INTEREST
In an Era of Partisan Stalemate, What Drug Pricing Policies Can the Executive Branch Enact Without Congressional Authority?
New York, New York, United States
photo
Ivan Plavec
CBO, IMAGINAB
ImaginAb, Inc.
Inglewood, California, United States
photo
Debbie Plouffe
VP BUSINESS DEVELLOPMENT, THE CENTER FOR AQUACULTURE TECHNOLOGIES
The Center for Aquaculture Technologies
Souris, Prince Edward Island, Canada
photo
Jonathan Polak
CEO, MESENTECH INC
Mesentech Inc
Vancouver, British Columbia, Canada
photo
Brian Pomper
PARTNER, AKIN GUMP STRAUSS HAUER & FELD LLP
International Trade in the Times of COVID-19
Washington, United States
photo
Richard Pops
CHAIRMAN & CEO, ALKERMES, INC.
FDA Town Hall
Waltham, Massachusetts, United States
photo
Michael Postow
MEDICAL ONCOLOGIST, MEMORIAL SLOAN KETTERING CANCER CENTER
What Was Hot at ASCO 2020? Highlights from the World’s Biggest Oncology Meeting
New York City, New York, United States
photo
Steven Powell
CHAIRMAN, CAMBRIDGE COGNITION
Digital Biomarkers: A New Dawn in CNS R&D
Cambridge, United Kingdom
photo
Michal Preminger
HEAD, JOHNSON & JOHNSON INNOVATION, EAST NORTH AMERICA, JOHNSON & JOHNSON INNOVATION
Brave Innovations: Public and Private Solutions to Advance Alzheimer’s Therapeutics and Diagnostic in a Risk-Averse Climate
Derisking Early Research and Increasing Likelihood of Clinical Success
Cambridge, Massachusetts, United States
photo
Amy Price
CONSULTANT AND PATIENT ADVOCATE
Patient Engagement in Gene and Cell Therapy: What is Different?
Omaha, Nebraska, United States
photo
Daryl Pritchard
SENIOR VICE PRESIDENT, SCIENCE POLICY, PERSONALIZED MEDICINE COALITION
Access to Personalized Medicine Drives Utilization of Genomic Tests and Targeted Therapies
Washington, District Of Columbia  , United States
photo
Dennis Purcell, MBA
FOUNDER AND SENIOR ADVISOR, AISLING CAPITAL
Striking the delicate balance of externalizing biopharma R&D to maximize innovation: Strategies to buy vs. build
New York, New York, United States
Load More